TOBACCO SMOKING AND NICOTINE NEUROPSYCHOPHARMACOLOGY - SOME FUTURE-RESEARCH DIRECTIONS

Authors
Citation
Ef. Domino, TOBACCO SMOKING AND NICOTINE NEUROPSYCHOPHARMACOLOGY - SOME FUTURE-RESEARCH DIRECTIONS, Neuropsychopharmacology, 18(6), 1998, pp. 456-468
Citations number
184
Categorie Soggetti
Neurosciences,Psychiatry,"Pharmacology & Pharmacy
Journal title
Neuropsychopharmacology
ISSN journal
0893133X → ACNP
Volume
18
Issue
6
Year of publication
1998
Pages
456 - 468
Database
ISI
SICI code
0893-133X(1998)18:6<456:TSANN->2.0.ZU;2-U
Abstract
Although nicotine is acknowledged as the major pharmacologically activ e chemical in tobacco that accounts for its continued use, there is a need for much further research. It is necessary to systematically comp are the complex pharmacological actions of pure nicotine with those of tobacco, using different routes of administration and, therefore, rat es of absorption. Tobacco smoking produces several important behaviora l and central nervous system effects. More research is needed to deter mine the role of nicotine versus the many of her substances present in tobacco smoke. Although nicotine is the primary pharmacological agent in tobacco that maintains its use, other chemicals and their biologic al mechanisms involved in tobacco smoking need to be studied further. (C) 1998 American College of Neuropsychopharmacology. Published by Els evier Science Inc.